Skip to content
Subscriber Only

CureVac CEO Warns Vaccine Hoarding Could Limit mRNA Shots

Franz-Werner Haas
Franz-Werner HaasPhotographer: Thomas Kienzle/AFP/Getty Images

Vaccine nationalism could undermine efforts to produce more Covid-19 shots from novel messenger-RNA technology because the supply chain includes elements that are already scarce, according to CureVac NV’s chief executive officer.

Components needed for making genetic material in the vaccines -- along with the lipid nanoparticles that surround it -- are currently difficult to source in large volumes, since the mRNA industry was so small before the pandemic. Suddenly, companies including Pfizer Inc., BioNTech SE and Moderna Inc. are looking to produce billions of doses of mRNA Covid shots.